Posts by Writing Staff | Beacon Examiner

Posts From Writing Staff

Two Industries That Could Thrive Using Virtual Reality

The year 2016 will most likely be remembered in the technology industry as the year that virtual reality finally broke into the mainstream. After years spent attempting to sell the

NFL Award Predictions For Bettors

Now that we’re halfway through the NFL season, it’s worth talking about the year-end awards. Though there is still a lot of football left to play, and though so much

Infinity Pharmaceuticals Flirts With 52-Week Low

Infinity Pharmaceuticals (INFI) shares fell to flirt with the 52-week low on Monday after the company lowered the revenue guidance range for 2015 while seeing a smaller than previously expected

Quest Diagnostics’ Simplexa Test Kit Gets FDA Clearance for 53 Additional Virus Strains

Quest Diagnostics (DGX), a provider of diagnostic testing information services, said Tuesday that its Focus Diagnostics subsidiary has received a 510(k) clearance from the U.S. Food and Drug Administration for

European Equities Close Higher as Auto & Consumer Stocks Lift Shares

European equities closed comfortably higher on Tuesday fueled by a rally in the automobile and consumer sectors. The rally came despite a 1.8% month-on-month contraction in new manufacturing orders in

RetailMeNot Names Marissa Tarleton as Chief Marketing Officer – North America

RetailMeNot (SALE), a digital coupon marketplace, said Tuesday that it has appointed Marissa Tarleton as chief marketing officer for North America. In her new role, Tarleton will direct all consumer

Eli Lilly Says to Present Evidence of Psoriasis Drug’s Potentia

Eli Lilly and Company (LLY) shares are lower 4% on Tuesday even after the pharmaceutical company said it will present positive results from the psoriasis drug ixekizumab clinical development program

Health Care Stocks Sharply Lower

Health care stocks were sharply lower, with the NYSE Health Care Index retreating almost 2.4% while shares of health care companies in the S&P 500 were down nearly 3.2% as

Energy XXI Shares Surge 16%

Energy XXI (Bermuda) (EXXI) shares are higher nearly 16% on Tuesday after the oil and natural gas company filed a registration with the Securities and Exchange Commission for the sale

The Female Health Company Expects 43% Increase in FC2 Unit Sales

Shares of The Female Health Company (FHCO) are 8% higher Tuesday midday after the company said it expects to report FC2 female condom unit sales of 61 million for the

Blue Earth Files Amended 10K/A for Fiscal 14

Shares of Blue Earth Inc. (BBLU) are surging Tuesday after the renewable energy company filed an amended Form 10K/A to present on a retroactive basis the effects of certain events,

Alkermes Gets FDA Approval for Schizophrenia Treatment Aristada

Alkermes (ALKS), a biopharmaceutical company, said Tuesday the U.S. Food and Drug Administration has approved ARISTADA extended-release injectable suspension to treat schizophrenia. The company is preparing to launch the drug

Previous Page 1 2 3 4 … 6 Next Page

Posts From Writing Staff

Loading, Please Wait!